title: Rapid identification of dysregulated genes in cutaneous malignant melanoma metastases using cDNA technology.
abstract: One important application of DNA microarray technology is the simultaneous analysis of gene expression of different mRNAs. Comparison of mRNA patterns of diseased and healthy tissue may help to understand the pathogenesis of a given disorder. In cancer tissue, identified dysregulated genes may serve as new molecular markers for diagnosis or prognosis or may ideally serve as new targets for therapy. Using membrane cDNA array technology, we analyzed gene expression in human melanomas, one of the most aggressive types of cancer with a high metastatic potential and with markedly increased incidence worldwide. To account for the heterogeneity of tumors, we compared total RNA from cutaneous melanoma metastases of 10 different patients with primary human melanocytes. An abundance of genes was dysregulated (up-/downregulated), which involved for example the apoptosis gene growth factor receptor-bound protein 10, Bcl2-associated X membrane protein, Bcl2 antagonist of cell death, glutathione S-transferase theta(1) and glutathione reductase. Ultimately, the identification of melanoma-associated genes may provide a potential therapeutic strategy for identifying and targeting malignant melanoma.
authors.affiliation: Department of Dermatology, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
authors.forename: Alireza
authors.initials: A
authors.lastname: Mirmohammadsadegh
authors.forename: Annett
authors.initials: A
authors.lastname: Baer
authors.forename: Sandeep
authors.initials: S
authors.lastname: Nambiar
authors.forename: Walter
authors.initials: W
authors.lastname: Bardenheuer
authors.forename: Ulrich R
authors.initials: UR
authors.lastname: Hengge
mesh_terms: D002352:Carrier Proteins / Q000235:genetics; D015536:Down-Regulation; D051383:GRB10 Adaptor Protein; D020869:Gene Expression Profiling; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D008544:Melanocytes / Q000378:metabolism; D008545:Melanoma / Q000235:genetics* / Q000556:secondary; D020411:Oligonucleotide Array Sequence Analysis; D011506:Proteins / Q000235:genetics; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000235:genetics; D012878:Skin Neoplasms / Q000235:genetics*; D015854:Up-Regulation; D051028:bcl-2-Associated X Protein; D051025:bcl-Associated Death Protein; D051020:bcl-X Protein
chemical_list: C494819:BAD protein, human; C494811:BCL2L1 protein, human; D002352:Carrier Proteins; C096358:GRB10 protein, human; D011506:Proteins; D019253:Proto-Oncogene Proteins c-bcl-2; D051028:bcl-2-Associated X Protein; D051025:bcl-Associated Death Protein; D051020:bcl-X Protein; D051383:GRB10 Adaptor Protein